DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,104 filers reported holding DANAHER CORPORATION in Q4 2023. The put-call ratio across all filers is 0.65 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $3,898,103 | +1.9% | 15,602 | +1.8% | 1.40% | -2.6% |
| Q1 2024 | $3,826,801 | +16.9% | 15,324 | +8.3% | 1.44% | +8.2% |
| Q4 2023 | $3,273,611 | -3.0% | 14,151 | +4.0% | 1.33% | -13.5% |
| Q3 2023 | $3,376,558 | -0.5% | 13,610 | +1.1% | 1.53% | -1.2% |
| Q2 2023 | $3,393,848 | +91.6% | 13,466 | +91.6% | 1.55% | +40.9% |
| Q1 2023 | $1,771,214 | -50.0% | 7,028 | -47.4% | 1.10% | -36.9% |
| Q4 2022 | $3,543,949 | +95.7% | 13,352 | +90.4% | 1.74% | +26.5% |
| Q3 2022 | $1,811,000 | -46.9% | 7,011 | -47.9% | 1.38% | -22.5% |
| Q2 2022 | $3,408,000 | -11.3% | 13,445 | +2.7% | 1.78% | +14.4% |
| Q1 2022 | $3,841,000 | -10.5% | 13,095 | +0.4% | 1.56% | -3.0% |
| Q4 2021 | $4,290,000 | +9.6% | 13,039 | +0.7% | 1.60% | -1.0% |
| Q3 2021 | $3,916,000 | +12.1% | 12,952 | -0.5% | 1.62% | +26.6% |
| Q2 2021 | $3,494,000 | +17.2% | 13,022 | -1.7% | 1.28% | +2.8% |
| Q1 2021 | $2,982,000 | +1.6% | 13,251 | +0.3% | 1.24% | -4.3% |
| Q4 2020 | $2,935,000 | +6.6% | 13,215 | +3.4% | 1.30% | -9.0% |
| Q3 2020 | $2,752,000 | +26.2% | 12,779 | +3.6% | 1.43% | +14.3% |
| Q2 2020 | $2,181,000 | +29.9% | 12,332 | +1.3% | 1.25% | +5.2% |
| Q1 2020 | $1,679,000 | +13.8% | 12,171 | +26.6% | 1.19% | +42.4% |
| Q4 2019 | $1,476,000 | +8.9% | 9,616 | +2.5% | 0.84% | -7.0% |
| Q3 2019 | $1,355,000 | +2.8% | 9,383 | +1.8% | 0.90% | +0.1% |
| Q2 2019 | $1,318,000 | +9.7% | 9,219 | +1.8% | 0.90% | +16.8% |
| Q1 2019 | $1,202,000 | +32.2% | 9,052 | +1.4% | 0.77% | +24.7% |
| Q4 2018 | $909,000 | +1.7% | 8,929 | +8.0% | 0.62% | +11.8% |
| Q3 2018 | $894,000 | +19.5% | 8,267 | +9.7% | 0.55% | +10.6% |
| Q2 2018 | $748,000 | +1366.7% | 7,535 | +1357.4% | 0.50% | +1176.9% |
| Q1 2018 | $51,000 | +6.2% | 517 | 0.0% | 0.04% | +8.3% |
| Q4 2017 | $48,000 | – | 517 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ace Management Global Ltd. | 168,488 | $42,096,727 | 12.36% |
| Zeno Equity Partners LLP | 182,612 | $45,660,122 | 12.15% |
| Defender Capital, LLC. | 135,187 | $33,776,567 | 11.54% |
| Bancreek Capital Management, LP | 56,267 | $14,058,310 | 10.98% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 214,830 | $53,664,407 | 9.84% |
| CADEN CAPITAL PARTNERS, LP | 104,501 | $26,109,575 | 9.44% |
| Dorsey Asset Management | 306,420 | $76,559,037 | 9.12% |
| Consulta Ltd | 500,000 | $124,925,000 | 8.51% |
| BOONE CAPITAL MANAGEMENT LLC | 106,360 | $26,574,046 | 6.93% |
| Manchester Global Management (UK) Ltd | 150,688 | $37,649,397 | 6.62% |